A professor in the Indiana School of Medicine is hopeful that an antibiotic cocktail he invented will one day improve the lives of millions of people, thanks in part to the Indiana University Research and Technology Corp., formed in 1997 to make work done by IU faculty and researchers available for commercial development.
The funds includes $7.6 million to study early-onset Alzheimer’s disease, $5.2 million to fund a clinical and translational sciences institute, and $4.8 million to fund epidemiologic databases to evaluate AIDS care in Africa.
A district court judge ruled Indiana University’s School of Dentistry and high-ranking members of its faculty did not violate a former clinic director’s rights by firing him for alleged sexual harassment of students.
The money will be awarded from IU’s Grand Challenges Program, a new push that is designed to tackle “major and large-scale problems facing humanity” that can only be addressed by multidisciplinary research teams.
Shortages of workers and investment dollars remain the two biggest challenges for Indiana’s life sciences industry, which otherwise is showing robust vital signs and embarking on high-profile collaborations.